preview

Company Analysis Of Medtronic, The World 's Largest Medical Technology Company Essay

Better Essays

Company Analysis Paper
Introduction
Medtronic is the world’s largest medical technology company. It was founded in 1949, as a medical equipment repair shop, by Earl Bakken and Palmer Hermundslie. Medtronic’s core products include implantable medical devices and drug and biological delivery devices such as pace makers and insulin pumps. The three year gross sales for Medtronic are: $15.933 billion in 2011, $16.184 billion in 2012, and$16.590 billion in 2013(NYSE, 2014). The three year net income reporting’s for Medtronic are: $3.181 billion in 2011, $3.392 billion in 2012, and $3.436 billion in 2013(Y-Charts, 2014). The stock price of Medtronic has increased in value by 13.41% since July of 2013. The forward annual dividend yield is 1.90% and there are 995.76 million shares outstanding (Medtronic, 2013). The dividend payments for Medtronic are currently $.305 cents per share, the dividend payments have been steadily climbing. In 2010 the dividend payment was only $.205 per share. Medtronic’s net profit margin is 20.9% compared to the healthcare industry standard of 16.99% (NYSE, 2014). Medtronic’s income from continuing operations is $3.07 billion dollars (Medtronic, 2014). All of these key performance indicators reveal that Medtronic is good at making money. This paper will review the core competencies, management, financial statements, the annual report, significant events, economic analysis, future prospects, and recommendations for improvement to provide a summary of

Get Access